Skip to main content

Nikita Ashcherkin

House Staff
Medicine

Current Duke Appointments & Affiliations


Recent Scholarly Works


Are sodium-glucose co-transporter-2 inhibitors associated with improved outcomes in diabetic patients admitted to intensive care units with septic shock?

Journal article Acute and critical care · May 2024 BackgroundSodium-glucose cotransporter-2 inhibitors (SGLT2i) have been shown to reduce organ dysfunction in renal and cardiovascular disease. There are limited data on the role of SGLT2i in acute organ dysfunction. We conducted a study to assess t ... Full text Cite
View All Scholarly Works